3E Extension Study

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the long-term efficacy and safety of entecavir 0.5 mg/d + adefovir 10 mg/d for treatment experienced chronic hepatitis B patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanfang Hospital of Southern Medical University
• Collaborator: Major Science and Technology Special Project of China 12th Five-year
• Treatments: Adefovir; Adefovir dipivoxil; Entecavir

Criteria

Inclusion Criteria:

• Subjects who completed the EXPLORE or EXCEL studies, or subjects with hepatitis flare after treatment withdrawal in EFFORT study.

• Subjects who are willing to participate the extension study.

Exclusion Criteria:

• Subjects who could not compliance with the protocol judged by investigators